HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories
News

Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories

By September 11, 2024No Comments1 min read

ANNOUNCEMENT – INDONESIA
We are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML).

“To whom it may concern,
PML would like to announce that as of 1 August 2024, the production, marketing and commercialization of Nutrimore Neuropar have been discontinued for good. This decision is the result of an amicable and mutual agreement between Moleac and PML in relation to the alleged violation of Moleac’s IP rights by PML.
This statement is not an admission of liability by either party.”

Access the announcement HERE: https://www.instagram.com/p/C_j7lEgT2Ym/?igsh=ZjByYzc4b2dmdmtq&img_index=1